#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    X-linked lymphoproliferative syndrome Philadelphia positive acute lymphocytic leukaemia Osteomyelitis Wolfram syndrome Human papilloma virus immunisation Immune-mediated myasthenia gravis Aplastic anaemia Rosai-Dorfman syndrome Haemophilia A without inhibitors Myelofibrosis Gastroenteropancreatic neuroendocrine tumour disease Nephroblastoma Encephalitis autoimmune Epilepsy Endometrial cancer recurrent More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Trials in Disease Chordoma – Life with Disease Loeys-Dietz syndrome – Diagnostics Angiosarcoma – Diagnostics Alport’s syndrome – Life with Disease Chronic granulomatous disease Rhabdoid tumour – Basic Information Pleural mesothelioma malignant – Basic Information Glycogen storage disease type V – Life with Disease Lymphangioma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vafidemstat Vonicog Alfa Ivospemin Bempikibart Niraparib Siremadlin N-Tec Avacopan Bms-986435 A49 Av-Ec2023 Obeticholic Acid [18F]DED Prucalopride Sodium Acetate (1-13C) Mr0005 Ambrosia Artemisiifolia (302) NVG-2089 Cemdisiran Abacavir More therapies…

    Learn about Your Condition

    Rhabdomyosarcoma recurrent Immune thrombocytopenia Phaeochromocytoma Migraine Leukaemia Inflammatory bowel disease Lymphocytic leukaemia Supraventricular tachycardia Mixed dementia Extra-osseous Ewing's sarcoma Impaired gastric emptying Endometrial cancer Somatic symptom disorder Vaginal cancer Endometriosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Jules Bordet

Institut Jules Bordet

Mijlenmeersstraat 90, Anderlecht, 1070, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Gemcitabine
    • Lacutamab
    • Oxaliplatin
    Belgium France Germany Spain

  • Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

    Not recruiting

    3 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Graft versus host disease
    Investigated Drugs:
    • Itolizumab
    Belgium France Germany Italy Portugal Spain

  • Study Comparing Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin versus High-Dose Chemotherapy with Paclitaxel and Drug Combination for Relapsed Germ Cell Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Testicular germ cell cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Etoposide
    Belgium Denmark France Germany Ireland Italy +2

  • Study of Regorafenib and Nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer stage II
    • Rectal cancer stage III
    Investigated Drugs:
    • Nivolumab
    • Regorafenib
    Belgium

  • Study of QEL-001 (CAR T regulatory cell therapy) to prevent liver transplant rejection in patients with HLA-A2 positive donor organ

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Liver transplant rejection
    Investigated Drugs:
    • Autologous T Regulatory Cells Expressing An Hla-A2-Specific Chimeric Antigen Receptor
    Belgium Spain

  • Study of trastuzumab deruxtecan treatment in patients with advanced HER2-positive breast cancer with or without brain metastases

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Belgium Denmark Germany Ireland Italy Poland +2

  • Study of Nivolumab, Ipilimumab, Relatlimab, and Daratumumab in Patients with Recurrent and Metastatic Colon Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Daratumumab
    • Ipilimumab
    • Nivolumab
    Belgium Italy

  • Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated Drugs:
    • Enasidenib Mesilate
    • Ivosidenib
    Austria Belgium Estonia Finland France Germany +6

  • Study on the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin and Sodium Thiosulfate for Ovarian Cancer Patients Undergoing Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Cisplatin
    • Sodium Thiosulfate
    Belgium France

  • Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Anakinra
    • Bendamustine Hydrochloride
    • Buclizine Hydrochloride
    Austria Belgium Denmark Finland France Germany +7
Previous Page
1 … 12 13 14 15 16 … 22
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!